-
Track & Monitor
Immuno-oncology in Pharmaceuticals: Genetic engineered chimeric antibodies
Innovation in the pharmaceuticals industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in pharmaceuticals industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Track & Monitor
Innovation in Pharmaceuticals: Cytokine activate T-cell based compositions
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Pharmaceuticals industry’s Cytokine activate T-cell based compositions segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or...
-
Track & Monitor
Innovation in Pharmaceuticals: Genetically modified fusion polypeptides
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Pharmaceuticals industry’s Genetically modified fusion polypeptides segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Track & Monitor
Internet of Things in Healthcare: Sensor Integrated Absorbent Pads
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Sector Analysis
Top 50 Global Hypermarkets, Supermarkets and Hard Discounters Retailers Sales, Market Share, Positioning and Key Performance Indicators (KPIs)
This brief lists the Top 50 Hypermarkets, Supermarkets and Hard Discounters by sales in 2020, which includes sales tax, per calendar year, making the data and market shares comparable.
-
Sector Analysis
Top 50 Global Retailers, 2020 Update – Sales, Market Share, Positioning and Key Performance Indicators (KPIs)
This brief lists the Top 50 global retailers by sales in 2020, which includes sales tax, per calendar year, making the data and market shares comparable.
-
Sector Analysis
Top 50 Global Food and Grocery Retailers, 2020 Update – Sales, Market Share, Positioning and Key Performance Indicators (KPIs)
This brief lists the Top 50 global food and grocery retailers by sales in 2020, which includes sales tax, per calendar year, making the data and market shares comparable.
-
Product Insights
Pancreatic Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Pancreatic Cancer Diagnostic Tests include assays of mostly antibodies released in response to a pancreatic cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Pancreatic Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Pancreatic Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Product Insights
Prostate Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Prostate Cancer Diagnostic Tests include assays of mostly antibodies released in response to a prostate cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Prostate Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Prostate Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Prostate Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...